Clinical Trial: Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder

U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704762) titled 'Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress Disorder' on July 02.

Brief Summary: This study is a Phase 2, randomized, double-blind, active-controlled, two-arm, single-site clinical trial designed to evaluate the safety, tolerability, and feasibility of MDMA-Assisted Therapy (MDMA-AT) for Service Members (Active Duty, Guard, or Reserve) diagnosed with moderate-to-severe Post-Traumatic Stress Disorder (PTSD) within a Military Health System (MHS) setting.

The trial incorporates Acceptance and Commitment Therapy (ACT) as a core therapeutic modality. Participants will receive MDMA-AT ut...